FR2680466A1 - PREPARATION FOR WHITENING THE SKIN. - Google Patents
PREPARATION FOR WHITENING THE SKIN. Download PDFInfo
- Publication number
- FR2680466A1 FR2680466A1 FR9210195A FR9210195A FR2680466A1 FR 2680466 A1 FR2680466 A1 FR 2680466A1 FR 9210195 A FR9210195 A FR 9210195A FR 9210195 A FR9210195 A FR 9210195A FR 2680466 A1 FR2680466 A1 FR 2680466A1
- Authority
- FR
- France
- Prior art keywords
- composition according
- weight
- extract
- dications
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Abstract
La présente invention est relative à une préparation de blanchiment de la peau. Cette composition peut être sous forme de solution, de crèmes, de gels, de sprays et analogues, comprenant une combinaison d'une quantité efficace d'un flavanoïde et d'une quantité efficace d'acide ascorbique ou d'un dérivé approprié de celui-ci, si souhaité en combinaison avec un filtre solaire, un agent conçu pour supprimer l'activité de la tyrosinase ou un dérivé de tocophéryle.The present invention relates to a preparation for bleaching the skin. This composition may be in the form of a solution, creams, gels, sprays and the like, comprising a combination of an effective amount of a flavanoid and an effective amount of ascorbic acid or a suitable derivative thereof. here, if desired in combination with a sunscreen, an agent designed to suppress tyrosinase activity or a tocopheryl derivative.
Description
PREPARATION DE BLANCHIMENT DE LA PEAUPREPARATION FOR WHITENING THE SKIN
La présente invention se rapporte à de nouvelles compositions cosmétiques pour application locale, Ces compositions sont des préparations décolorantes et elles peuvent être de n'importe quelle forme classique pour ap- plication locale, comme des crèmes, des gels, des lotions, des sprays et analogues. Les préparations décolorantes ont pour résultat un blanchiment de la peau de l'utilisateur et elles empêchent The present invention relates to novel cosmetic compositions for topical application. These compositions are bleaching preparations and may be of any conventional form for topical application, such as creams, gels, lotions, sprays and the like. like. Bleaching preparations result in bleaching of the user's skin and prevent
également dans une large mesure la formation de nouvelles taches sombres sur la peau de l'utilisateur. also to a large extent the formation of new dark spots on the skin of the user.
Le mélanocyte est le lieu de production de pig- ment dans la peau Les mélanocytes produisent des mélanosomes, The melanocyte is the site of pigmentation in the skin Melanocytes produce melanosomes,
organelles liés aux membranes dans le cytoplasme du mélano- cyte, qui sont alors transférés aux kératinocytes voisins. organelles bound to membranes in the cytoplasm of the melanocyte, which are then transferred to neighboring keratinocytes.
La mélanine, qui est formée dans les mélanosomes, est res- ponsable de la couleur de base de la peau humaine Dans la voie biosynthétique de la mélanine, la tyrosinase, une en-20 zyme contenant du cuivre, joue un rôle important dans le degré de production de pigment La couleur de la peau est apparente seulement lorsque des mélanosomes contenant de la mélanine sont transférés dans les kératinocytes. Plusieurs causes, incluant le contrôle génétique et des facteurs d'environnement tels que le rayonnement ultraviolet, et des hormones, régulent la mélanogénèse Des Melanin, which is formed in melanosomes, is responsible for the basic color of human skin. In the biosynthetic pathway of melanin, tyrosinase, a copper-containing enzyme, plays an important role in the degree of melanosome. The color of the skin is apparent only when melanosomes containing melanin are transferred into the keratinocytes. Several causes, including genetic control and environmental factors such as ultraviolet radiation, and hormones, regulate melanogenesis.
réactions anormales des mélanocytes aux causes ci-dessus peuvent-avoir pour résultat une augmentation de l'accumula- tion de mélanine dans la peau sous la forme de taches bru-30 nes. Abnormal reactions of melanocytes with the above causes may result in increased accumulation of melanin in the skin in the form of brown spots.
La présente invention se rapporte à de nouvelles compositions cosmétiques pour application locale sur la The present invention relates to novel cosmetic compositions for local application on the
peau d'un utilisateur, qui ont pour résultat un blanchiment de la peau et qui empêchent dans une large mesure la35 formation de taches brunes. skin of a user, which result in bleaching of the skin and which largely prevent the formation of brown spots.
Les compositiows de l'invention consistent en des The compositiows of the invention consist of
combinaisons de flavonoedes, qui sont efficaces pour élimi- combinations of flavonoids, which are effective in eliminating
ner ou au moins pour réduire grandement la quantité des pigments qui ont été formés dans la peau comme résultat des rayonnements UV, et d'acide ascorbique ou d'un dérivé appro- at least to greatly reduce the amount of pigments that have formed in the skin as a result of UV radiation, and ascorbic acid or a suitable derivative.
prié de celuirci L'acide ascorbique (ou ses dérivés physio- of ascorbic acid (or its physio-
logiquement tolérables) ont pour résultat la réduction de la DOPA?quinone en DOPA, et également convertit la mélanine oxydée colorée en une forme réduite incolore de celle-ci On utilise avantageusement des dérivés flavonoïdes d'extraits logically tolerable) result in the reduction of DOPA-quinone to DOPA, and also convert the colored oxidized melanin to a reduced colorless form thereof. Advantageously, flavonoid derivatives of extracts are used.
de plantes, ou des extraits de plantes tels quels qui con- of plants, or extracts of plants as such which
tiennent une concentration adéquate de tels flavonoi'des Des flavonoides de synthèse peuvent également être utilisés Les maintain an adequate concentration of such flavonoids Synthetic flavonoids can also be used.
compositions de la présente invention sont également appro- compositions of the present invention are also suitable
priées pour la réduction de la formation de mélanine dans required for the reduction of melanin formation in
des stades précoces d'une telle formation, et pour la pré- early stages of such training, and for the pre-
vention de la formation de nouvelles taches Les nouvelles compositions décolorantes de cette invention exercent un effet blanchissant et éclaicissant prononcé sur les taches brunes de la peau, Des extraits de plantes préférés pour utilisation selon l'invention sont ceux obtenus à partir de l'achillée millefeuille, le calendula, la sauge, l'hamamélis et les mûres. The new bleaching compositions of this invention exert a pronounced whitening and brightening effect on the brown spots of the skin. Preferred plant extracts for use according to the invention are those obtained from yarrow , calendula, sage, witch hazel and blackberries.
Les préparations de l'invention contiennent avan- The preparations of the invention contain
tageusement un support ou vecteur convenable, et également un ou plusieurs composants additifs sélectionnés à partir des dérivés de toconhérol, de l'acide kojique, de filtres solaires chimiques et physiques des UVA, des UVB, des IR et/ou de la a suitable carrier or carrier, and also one or more additive components selected from the derivatives of toconterol, kojic acid, sunscreens chemical and physical UVA, UVB, IR and / or
lumière visible; des minéraux tels que le dioxyde de ti- visible light; minerals such as titanium dioxide
tane Les filtres solaires convenables sont de la forme tane Suitable sunscreens are of the form
facilement disponibles commercialement, comme le méthoxy- readily available commercially, such as methoxy-
cinnamate d'octyle, le méthoxydibenzoylméthane de butyle, octyl cinnamate, butyl methoxydibenzoylmethane,
etc Une grande variété de formulations peuvent être uti- etc. A wide variety of formulations can be used
lisées et les exemples suivants indiquent quelques types possibles de leurs formulations, and the following examples indicate some possible types of their formulations,
D'une manière générale, les formulations de l'in- In a general way, the formulations of the in-
vention contiennent comme ingrédients à partir d'environ 0,1 %, en poids, d'un extrait d'un ou plusieurs des éléments suivants; l'achillée millefeuille, le calendula, la sauge, as ingredients from about 0.1%, by weight, of an extract of one or more of the following; yarrow, calendula, sage,
l'hamamélis et les mères, D'autres extraits de plantes con- witch hazel and mothers, Other herbal extracts
tenant des quantités appréciables de flavonoïdes peuvent être utilisés Les formulations contiennent d'une manière générale à partir d'environ 0, 1 % en poids à environ 30 % en poids de flavanoïde purifié, ou un extrait de plantes contenant une quantité équivalente de flavanoïdes Le second ingrédient est un dérivé physiologiquement tolérable de l'acide ascorbique, comme le palmitate d'ascorbyle, le stéarate d'ascorbyle, le The formulations generally contain from about 0.1% by weight to about 30% by weight of purified flavanoids, or a plant extract containing an equivalent amount of flavanoids. second ingredient is a physiologically tolerable derivative of ascorbic acid, such as ascorbyl palmitate, ascorbyl stearate,
phosphate ascorbomagnésien et analogues Le second ingré- ascorbomagnesium phosphate and analogues The second
dient constitue d'environ 0,1 % à environ 5 % en poids de la composition. L'extrait de réglisse de 0,01 % en poids à environ % en poids est un composant préféré. It comprises from about 0.1% to about 5% by weight of the composition. Licorice extract from 0.01% by weight to about% by weight is a preferred component.
Les formulations avantageuses contiennent égale- The advantageous formulations also contain
ment comme ingrédient un filtre solaire approprié, comme par exemple un filtre des UVA, des UVB, des IR et/ou de la lumière visible; le méthoxycinnamate d'octyle, le méthoxydibenzoylméthane de as an ingredient a suitable sunscreen, such as a filter UVA, UVB, IR and / or visible light; octyl methoxycinnamate, methoxydibenzoylmethane
butyle Une autre substance supplémentaire d'un effet simi- butyl Another additional substance of a similar effect
laire est Ti O 2 En général ces ingrédients constituent d'en- In general, these ingredients constitute
viron 1 % en poids à environ 10 % en poids de la formulation. about 1% by weight to about 10% by weight of the formulation.
Un ingrédient optionnel supplémentaire avantageux est un An additional advantageous optional ingredient is a
dérivé approprié de tocophéryle, comme le linoléate de toco- suitable tocopheryl derivative, such as tocopheryl linoleate
phéryle Des composés de ce type, lorsqu'ils sont utilisés constituent d'environ 0,1 % en poids à environ 5 % en poids pheryl Compounds of this type when used comprise from about 0.1% by weight to about 5% by weight
de la formulation.of the formulation.
Un autre ingrédient optionnel avantageux, conçu Another advantageous optional ingredient, designed
pour supprimer l'activité de la tyrosinase, due probable- to suppress the activity of tyrosinase, probably caused by
ment à la chélation du cuivre, est l'acide kojique Cet ingrédient est utilisé à une concentration allant d'environ chelation of copper is kojic acid. This ingredient is used at a concentration
0,1 % en poids à environ 5 % en poids de la formulation. 0.1% by weight to about 5% by weight of the formulation.
Les exemples suivantes qui doivent être compris d'une manière non limitative, représentent la préparation d'un certain nombre de formulations efficaces de l'invention sous forme de crèmes de lotions, de sprays et de gels: EXEMPLE 1; Crème Extrait d'achillée millefeuille 20 % Palmitate ascorbomagnésien 5 % Base de crème pour compléter à: 100 EXEMPLE 2; Crème Extrait de mères 25 % Acide ascorbique 0,1 % Base de crème pour compléter à: 100 EXEMPLE 3: Crème Extrait d'achillée millefeuille 15 % Stéarate d'ascorbyle 5 % Ti O 2 10 % Base de crème pour compléter à: 100 EXEMPLE 4: Lotion Extrait d'achillée millefeuille 10 % Palmitate d'ascorbyle 0,5 % Méthoxycinnamate d'octyle 7,5 % Méthoxydibenzoylméthane butyle 0,5 % Ti O 2 10 % Acide kojique 3 % Base de lotion pour compléter à; 100 EXEMPLE 5: Lotion Extrait d'achillée millefeuille 5 % Palmitate d'ascorbyle 0,5 % Benzophénone 5 % Ti O 2 10 % Linoléate de tocophéryle 1 % Base de lotion pour compléter à: 100 EXEMPLE 6: Lotion Acide kojique 2 % Ti O 2 5 % Base de lotion pour compléter à; 100 The following examples which should be understood in a nonlimiting manner, represent the preparation of a number of effective formulations of the invention in the form of creams of lotions, sprays and gels: EXAMPLE 1; Cream Yarrow Extract 20% Ascorb Magnesium Palmitate 5% Cream Base to Complete to: 100 EXAMPLE 2; Cream Mothers extract 25% Ascorbic acid 0.1% Base cream to complete to: 100 EXAMPLE 3 Cream Yarrow extract 15% Ascorbyl stearate 5% Ti O 2 10% Cream base to complete to: 100 EXAMPLE 4 Lotion Yarrow Extract 10% Ascorbyl Palmitate 0.5% Octyl Methoxycinnamate 7.5% Methoxydibenzoylmethane Butyl 0.5% Ti O 2 10% Kojic Acid 3% Base Lotion to supplement; EXAMPLE 5 Lotion Yarrow extract 5% Ascorbyl palmitate 0.5% Benzophenone 5% Ti O 2 10% Tocopheryl linoleate 1% Lotion base to make up to: 100 EXAMPLE 6: 2% Ti kojic acid lotion O 2 5% Base lotion to supplement to; 100
EXEMPLE 7; GelEXAMPLE 7 Gel
Acide kojique 0,1 % Filtres solaires des UVA & UVB Base de gel pour compléter à: 100 EXEMPLE 8; Lotion Palmitate d'ascorbyle 0,1 % Linoléate tocophéryle 3 % Acide kojique 0,5 % Base de lotion pour compléter à: 100 EXEMPLE 9: Crème Ingrédients % Palmitate d'ascorbyle 4 Extrait soluble dans l'eau d'achillée Kojic acid 0.1% UVA & UVB solar filters Gel base to complete at: 100 EXAMPLE 8; Ascorbyl palmitate lotion 0.1% Linoleate tocopheryl 3% Kojic acid 0.5% Lotion base to supplement to: 100 EXAMPLE 9: Cream Ingredients Ascorbyl palmitate 4 Water soluble extract from yarrow
millefeuille (contenant 3 % de flavo- millefeuille (containing 3% of flavo-
noides) 1 Linoléate de tocophéryle 0,1 Méthoxycinnamate d'octyle 2 Méthoxydibenzoylméthane de butyle 0,75 Ti O 2 1 Acide kojique 0,1 Panthénol 1 Extrait de camomille 0,1 noides) 1 Tocopheryl linoleate 0.1 Octyl methoxycinnamate 2 Butyl methoxydibenzoylmethane 0.75 Ti O 2 1 Kojic acid 0.1 Panthenol 1 Chamomile extract 0.1
IPM 2IPM 2
BHT 0,04BHT 0.04
Conservateurs 0,5 Acide stéarique 4 Preservatives 0.5 Stearic Acid 4
NA 2 EDTA 0,1NA 2 EDTA 0.1
Phosphate de cétyle DEA 3,5 Alcool cétylique 2 Stéarate de glycérine 4 Eau pour compléter à: 100 EXEMPLE 10: Crème Ingrédients % Palmitate d'ascorbyle 0,1 Extrait soluble dans lteau d'achillée millefeuille (contenant 3 % de flavonoldes) 30 Linoléate de tocophéryle 5 Méthoxycinnamate d'octyle 7 Méthoxydibenzoylméthane de butyle 3 Ti O 2 10 Acide kojique 5 Panthénol, 1 Extrait de camomille 0,1 Cetyl phosphate DEA 3.5 Cetyl alcohol 2 Glycerin stearate 4 Water to make up to: 100 EXAMPLE 10: Cream Ingredients% ascorbyl palmitate 0.1 Water soluble extract of yarrow (containing 3% of flavonoid) 30 Linoleate tocopheryl 5 octyl methoxycinnamate 7 butyl methoxydibenzoylmethane 3 Ti O 2 10 kojic acid 5 panthenol, 1 chamomile extract 0.1
IPM 2IPM 2
BHT 0,04BHT 0.04
Conservateurs 0,5 Acide stéarique 4 Na 2 EDTA 0, 1 Phosphate de cétyle DEA 3,5 Alcool cétylique 2 Stéarate de glycérine 4 Eau pour compléter à: 100 EXEMPLE 11; Lotion Ingrédients % Palmitate d'ascorbyle 0,1 Extrait soluble dans l'eau d'achillée millefeuille (contenant 3 % de flavonoldes) 30 Linoléate de tocophéryle 5 Méthoxycinnamate d'octyle 7 Méthoxydibenzoylméthane de butyle 3 Ti O 2 10 Acide kojique 5 Panthénol 1 Extrait de camomille 0,1 Preservatives 0.5 Stearic acid 4 Na 2 EDTA 0, 1 Cetyl phosphate DEA 3.5 Cetyl alcohol 2 Glycerine stearate 4 Water to make up to: 100 EXAMPLE 11; Lotion Ingredients% Ascorbyl palmitate 0.1 Water soluble extract of yarrow (containing 3% flavonols) Tocopheryl linoleate 5 Methoxycinnamate octyl 7 Butyl methoxydibenzoylmethane 3 Ti O 2 10 Kohic acid 5 Panthenol 1 Chamomile extract 0.1
IPM 2IPM 2
BHT 0,04BHT 0.04
Conservateurs 0,5Conservatives 0.5
EXEMPLE 12EXAMPLE 12
EXEMPLE 13EXAMPLE 13
Acide stéarique 2Stearic acid 2
NA 2 EDTA 0,1NA 2 EDTA 0.1
Phosphate de cétyle DEA 3 P 5 Alcool cétylique 0,2 Stéarate de glycérine 2 Eau pour compléter à: 100 Lotion Ingrédients % Pallmitate ct' ascorbyle 4 Extrait soluble dans l'eau d'achillée millefeuille (contenant 3 % de flavonoldes) 1 Linoléate de tocophéryle 0,1 Méthoxycinnamate d'octyle 2 Méthoxydibenzoylméthane de butyle 0,75 Ti O 2 1 Acide Kojique 0,1 Panthénol 1 Extrait de camomille 0,1 Cetyl phosphate DEA 3 P 5 Cetyl alcohol 0.2 Glycerine stearate 2 Water to make up to: 100 Lotion Ingredients% Pallmitate and ascorbyl 4 Water soluble extract of yarrow (containing 3% flavonoid) 1 Linoleate tocopheryl 0.1 Octyl methoxycinnamate 2 Butyl methoxydibenzoylmethane 0.75 Ti O 2 1 Kojic acid 0.1 Panthenol 1 Chamomile extract 0.1
IPM 2IPM 2
BHT 0,04BHT 0.04
Conservateurs 0,5 Acide stéarique 2 Na 2 EDTA 0,1 Phosphate de cétyle DEA 3,5 Stéarate de glycérine 2 Eau pour compléter à: 100 : Gel Ingrédients' % Palmitate d'ascorbyle 0,5 Extrait soluble dans l'eau d'achillée millefeuille (contenant 3 % de flavono- des) 1 Polysorbate 6 Carbopol 1 Triéthanolamine 4,2 Conservateurs 1 Acide Kojique 5 Ti O 2 1 Linoléate de tocophéryle 2 Panthénol 1 Acide sulfonique de phénylbenzimidazol 5 6 Eau pour compléter à: 100 EXEMPLE 14; Gel Ingrédients % Palmitate d'ascorbyle 3 Extrait soluble dans l'eau d'achillée millefeuille (contenant 3 % de flavonoifdes) 25 Linoléate de tocophéryle 0,5 Polysorbate 6 Carbopol 1 Triéthanolamine 1,6 Conservateurs 1 Acide Kojique 0,1 Acide sulfonique de phénylbenzimidazol-5 0,1 Ti O 2 1 Panthénol 1 Eau pour compléter à: 100 EXEMPLE 15: Liquide Ingrédients % Palmitate d'ascorbyle 3 Extrait soluble dans l'eau d'achillée millefeuille (contenant 3 % de flavonoldes) 25 Linoléate de tocophéryle 0,5 Polysorbate 10 Triéthanolamine 0,05 Conservateurs I Acide kojique 0,1 Acide sulfonique de phénylbenzimridaz ol-5 0,1 Ti O 2 10 Panthénol 1 Eau pour compléter à 100 EXEMPLE 16: Liquide Ingrédients % Palmitate d'ascorbyle 0,5 Extrait soluble dans l'eau d'achillée millefeuille (contenant 3 % de flavonoïdes) 1 Polysorbate 10 -15 Conservateurs 1 Acide kojique 5 Ti O 2 1 Linoléate de tocophéryle 2 Panthénol 1 Acide sulfonique de phénylbenzimidazol-5 6 Triéthanolamine 3,1 Eau pour compléter à: 100 EXEMPLE 17: Gel Ingrédients % Palmitate d'ascorbyle 3 Extrait de mûres (sohakul) soluble dans l'eau 20 Linoléate de tocophéryle 0,5 Polysorbate 6 Carbopol 1 Triéthanolamine 4,2 Conservateurs 1 Acide kojique 0,1 Acide sulfonique de phénylbenzimidazol-5 0,1 Panthénol 1 Eau pour compléter à; 100 EXEMPLE 18; Gel Ingrédients % Palmitate d'ascorbyle 0,5 Extrait de mûres (sohakul) soluble dans l'eau 1 Polysorbate 6 Carbopol 1 Triéthanolamine 4,2 Conservateurs 1 Acide kojique 5 Ti O 2 10 Linoléate de tocophéryle 1 Panthénol 1 Acide sulfonique de phénylbenzimidazol-5 6 Eau pour compléter à: 100 Preservatives 0.5 Stearic acid 2 Na 2 EDTA 0.1 Cetyl phosphate DEA 3.5 Glycerine stearate 2 Water to make up to: 100: Gel Ingredients'% Ascorbyl palmitate 0.5 Water soluble extract of Yarrow (containing 3% of flavonoids) 1 Polysorbate 6 Carbopol 1 Triethanolamine 4.2 Preservatives 1 Kojic acid 5 Ti O 2 1 Tocopheryl linoleate 2 Panthenol 1 Phenylbenzimidazole sulfonic acid 5 Water to make up to: 100 EXAMPLE 14; Gel Ingredients% Ascorbyl palmitate 3 Water soluble yarrow extract (containing 3% flavonoids) Tocopheryl linoleate 0.5 Polysorbate 6 Carbopol 1 Triethanolamine 1.6 Preservatives 1 Kojic acid 0.1 Sulfonic acid Phenylbenzimidazol-5 0.1 Ti O 2 1 Panthenol 1 Water to make up to: 100 EXAMPLE 15: Liquid Ingredients% Ascorbyl palmitate 3 Water soluble extract of yarrow (containing 3% flavonoid) Tocopheryl linoleate 0.5 Polysorbate 10 Triethanolamine 0.05 Preservatives I Kojic acid 0.1 Phenylbenzimridazol-5 sulfonic acid 0.1 Ti O 2 Panthenol 1 Water to make up to 100 EXAMPLE 16: Liquid Ingredients% ascorbyl palmitate 0.5 Soluble extract in yarrow water (containing 3% flavonoids) 1 Polysorbate 10 -15 Preservatives 1 Kojic acid 5 Ti O 2 1 Tocopheryl linoleate 2 Panthenol 1 Phenylbenzimidazol-5 sulfonic acid 6 Triethanolamine 3.1 Water to complete to: EXAMPLE 17: Gel Ingredients% Ascorbyl palmitate 3 Water soluble blackberry extract (sohakul) Tocopheryl linoleate 0.5 Polysorbate 6 Carbopol 1 Triethanolamine 4.2 Preservatives 1 Kojic acid 0.1 Acid sulfonic acid phenylbenzimidazol-5 0.1 Panthenol 1 Water to supplement to; EXAMPLE 18; Gel Ingredients% Ascorbyl palmitate 0.5 Water soluble blackberry extract (sohakul) 1 Polysorbate 6 Carbopol 1 Triethanolamine 4.2 Preservatives 1 Kojic acid 5 Ti O 2 10 Tocopheryl linoleate 1 Panthenol 1 Phenylbenzimidazole sulfonic acid 5 6 Water to complete to: 100
EXEMPLE 19EXAMPLE 19
Ingrédients % Alcool cétylique 5 Stéarate de glycéryle SE 3 Triglycéride de capryle/caprylate 3 Distéarate P E G 6000 1 Extrait d'achillée millefeuille 1 Extrait de réglisse 0,05 Palmitate d'ascorbyle 0,5 Linoléate de tocophéryle 0,2 Dioxyde de titane 2 Acide glycolique 5 Conservateurs 9,5 Gomme de xanthane 0,3 NH OH pour obtenir PH-4 Eau pour compléter à: 100 Ingredients% Cetyl Alcohol 5 Glyceryl Stearate SE 3 Capryl Triglyceride / Caprylate 3 Distearate PEG 6000 1 Yarrow Extract 1 Licorice Extract 0.05 Ascorbyl Palmitate 0.5 Tocopheryl Linoleate 0.2 Titanium Dioxide 2 Acid Glycolic 5 Preservatives 9.5 xanthan gum 0.3 NH OH to obtain PH-4 Water to supplement to: 100
EXEMPIS 20EXEMPIS 20
Ingrédients % Extrait d'achillée millefeuille 2 Acide kojique 0,5 Palmitate d'ascorbyle 0,2 Acide hydroxylique (comme l'acide glycolique) 5 Base de lotion pour compléter à: 100 Dans les exemples suivants l'extrait de réglisse utilisé était de l'extrait de réglisse TP (Glycyrrhiza Ingredients% Yarrow extract 2 Kojic acid 0.5 Ascorbyl palmitate 0.2 Hydroxylic acid (such as glycolic acid) 5 Lotion base to supplement to: 100 In the following examples the licorice extract used was TP licorice extract (Glycyrrhiza
Glabra) produit par Nikko Chemicals, Japon Les pourcenta- Glabra) produced by Nikko Chemicals, Japan The percentages
ges sont en poids.are by weight.
EXEMPLE 21EXAMPLE 21
Ingrédients % Extrait de réglisse 0,05 Extrait d'achillée millefeuille 3,0 Palmitate d'ascorbyle 0,5 Base de crème pour compléter à: 100 Ingredients% Licorice Extract 0.05 Yarrow Extract 3.0 Palmitate Ascorbyl 0.5 Base Cream to Complete to: 100
EXEMPLE 22EXAMPLE 22
Ingrédients % Extrait de réglisse 0,1 Palmitate d'ascorbyle 1,0 Linoléate de tocophéryle 0,5 Base de lotion pour compléter à: 100 Ingredients% Licorice Extract 0.1 Ascorbyl Palmitate 1.0 Tocopheryl Linoleate 0.5 Base Lotion to Complement to: 100
EXEMPLE 23EXAMPLE 23
Ingrédients % Extrait de réglisse 4,0 Extrait d'achillée millefeuille 3,0 Linoléate de tocophéryle 0,5 Méthoxydibenzoylméthane de butyle 1,5 Dioxyde de titane 5,0 Extrait de camomille 0,1 Ingredients% Licorice Extract 4.0 Yarrow Extract 3.0 Tocopheryl Linoleate 0.5 Butyl Methoxydibenzoylmethane 1.5 Titanium Dioxide 5.0 Chamomile Extract 0.1
I P M 2,0I P M 2,0
BHT 0,04BHT 0.04
Conservateurs 0,5 Acide stéarique 2,0 Na EDTA 0,1 Phosphate de cétyle DEA 3,5 Alcool cétylique 0, 2 Stéarate de glycérine 2,0 Eau pour compléter à: 100 Des expérimentations extensives ont été exécutées Preservatives 0.5 Stearic acid 2.0 Na EDTA 0.1 Cetyl phosphate DEA 3.5 Cetyl alcohol 0, 2 Glycerin stearate 2.0 Water to make up to: 100 Extensive experiments have been performed
qui ont conduit aux compositions de la présente invention. which led to the compositions of the present invention.
Les critères utilisés dans les évaluations étaient des échelles arbitraires de valeur de 0, 1, 2 et 3 en ce qui concerne le nombre des taches, en ce qui concerne The criteria used in the evaluations were arbitrary scales of values of 0, 1, 2 and 3 with regard to the number of spots, as far as
la couleur des taches et les niveaux de contraste Les ty- stain color and contrast levels.
pes de peau ont été classés en quatre catégories selon l'im- of skin have been classified into four categories according to
portance des brûlures solaires et la facilité du bronzage. lift of sun burns and ease of tanning.
Les expérimentations ont été exécutées avec des sujets hu- The experiments were carried out with human subjects
mains femmes et hommes qui avaient accepté les essais Les âges allaient de 50 à 92 ans, et seuls ont été testés des hands women and men who had accepted the tests The ages ranged from 50 to 92 years, and only were tested
sujets qui avaient des taches de vieillesse symétriques bi- subjects who had bi-symmetrical age spots
latérales sur la face dorsale des deux mains, qui avaient on the dorsal side of both hands, which had
un nombre adéquat de telles taches, d'une couleur suffisam- an adequate number of such stains of sufficient color
ment sombre et contrastée.dark and contrasting.
Les tests ont été exécutés avec les composants principaux, chacun par lui-même, et ensuite, différentes The tests were run with the main components, each by itself, and then, different
combinaisons ont été testées, et des dosages (concentra- combinations were tested, and assays (concentration
tions) différents ont été utilisés. different) were used.
L'acide ascorbique et ses dérivés ont exercé un Ascorbic acid and its derivatives exerted a
certain effet, mais à des doses relativement élevées Ega- certain effect, but at relatively high doses
lement les différents flavonordes mentionnés ont été tes- the various flavonordes mentioned were testified
tés en eux-mêmes, et ils ont un effet certain. in themselves, and they have a certain effect.
Il a été trouvé de façon surprenante que la combinaison de ces deux composants augmentait l'effet d'une manière prononcée, même lorsque des doses plus faibles qu'auparavant étaient utilisées L'addition à ceux-ci, soit It was surprisingly found that the combination of these two components increased the effect in a pronounced manner, even when lower doses than before were used. The addition to these, either
de dérivés de tocophéryle, soit d'acide kojique, a augmen- of tocopheryl derivatives, ie kojic acid, has
té davantage l'effet de blanchiment, et ceci également d'une manière qui peut être expliquée par un effet de synergie, the bleaching effect, and this also in a way that can be explained by a synergistic effect,
Il est vraisemblable que les différents compo- It is likely that the different compounds
sants, et spécialement l'acide ascorbique et ses dérivés, de même que les flavonoldes exercent leur effet par diffé- rentes voies, Ceci s'applique également à l'acide kojique qui vitamins, especially ascorbic acid and its derivatives, as well as flavonoids exert their effect by different routes. This also applies to kojic acid which
apparemment rend inactive une enzyme favorisant la forma- apparently inactivates an enzyme promoting the formation of
tion de mélanine L'effet de blanchiment aes c Oaitpeirioule t De Melanin The bleaching effect of
la présente invention est un effet très prononcé et néces- the present invention is a very pronounced effect and requires
site l'application d'une formulation de l'invention pendant site the application of a formulation of the invention during
environ 2 à 3 mois.about 2 to 3 months.
Comme indiqué ci-dessus, il est très vraisembla- As indicated above, it is very likely that
ble que l'acide ascorbique et ses dérivés en même temps que les flavonoides définis, exercent un effet de synergie, ce that ascorbic acid and its derivatives together with the defined flavonoids exert a synergistic effect,
qui est en outre favorisé par des composants comme le toco- which is further favored by components such as toco-
phérol ou l'acide kojique.phérol or kojic acid.
Claims (11)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL99291A IL99291A (en) | 1991-08-23 | 1991-08-23 | Cosmetic preparations |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2680466A1 true FR2680466A1 (en) | 1993-02-26 |
FR2680466B3 FR2680466B3 (en) | 1993-11-19 |
Family
ID=11062833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9210195A Expired - Lifetime FR2680466B3 (en) | 1991-08-23 | 1992-08-21 | PREPARATION OF SKIN WHITENING. |
Country Status (9)
Country | Link |
---|---|
AU (1) | AU654030B2 (en) |
CA (1) | CA2076467A1 (en) |
CH (1) | CH684739A5 (en) |
DE (1) | DE4227806A1 (en) |
ES (1) | ES2050074B1 (en) |
FR (1) | FR2680466B3 (en) |
GB (1) | GB2259014B (en) |
IL (1) | IL99291A (en) |
PT (1) | PT100800B (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2708851A1 (en) * | 1993-08-12 | 1995-02-17 | Oreal | Cosmetic composition comprising the combination of a nanopigment of metal oxides and an antioxidant, and use thereof for protecting the skin and the hair |
FR2712806A1 (en) * | 1991-12-19 | 1995-06-02 | Dowa Mining Co | Skin-cosmetic material having high whitening effect and safety |
FR2717386A1 (en) * | 1994-03-17 | 1995-09-22 | Fischer Pharma Ltd | Composition for whitening the skin. |
FR2723316A1 (en) * | 1994-08-04 | 1996-02-09 | Thorel Jean Noel | Compsn. for skin de-pigmentation caused by hyper:activation melanocytes |
EP0754449A1 (en) * | 1995-07-20 | 1997-01-22 | L'oreal | Skin whitening composition and/or anti-aging composition and uses thereof |
EP1075833A1 (en) * | 1999-07-22 | 2001-02-14 | The Secretary Of State For Defence | Barrier cream |
WO2002067886A3 (en) * | 2001-02-28 | 2003-03-20 | Colgate Palmolive Co | Skin composition |
EP1709964A2 (en) * | 2005-04-06 | 2006-10-11 | Engelhard Lyon | A method of cosmetic depigmentation care by applying at least one aurone |
FR2884250A1 (en) * | 2005-04-06 | 2006-10-13 | Coletica Sa | USE OF AURONES FOR THE DEPIGMENTING OR INHIBITING ACTIVITY OF MELANOGENESIS IN COSMETIC OR DERMATOLOGICAL COMPOSITIONS |
US7182949B2 (en) * | 2001-02-19 | 2007-02-27 | L'oreal | Composition comprising vitamin C prepared during application, use of enzymes for forming vitamin C for topical use, and a cosmetic treatment method |
FR3007981A1 (en) * | 2013-07-05 | 2015-01-09 | Oreal | ASSOCIATION OF EXTRACT OF HAMAMELIS VIRGINIANA, ESCIN, AND ASCORBIC ACID |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4444238A1 (en) * | 1994-12-13 | 1996-06-20 | Beiersdorf Ag | Cosmetic or dermatological drug combinations of cinnamic acid derivatives and flavone glycosides |
FR2735688B1 (en) * | 1995-06-26 | 1997-08-14 | Oreal | USE IN COMBINATION OF AN ALPHA-HYDROXYACID AND A TITANIUM OXIDE FOR SKIN WHITENING |
FR2736263B1 (en) * | 1995-07-07 | 1997-09-26 | C3D Sarl | DEPIGMENTING DERMOCOSMETIC COMPOSITION AND ITS USE |
FR2745179B1 (en) * | 1996-02-28 | 1998-04-10 | Gattefosse Holding | ACTIVE MASTER MIXTURE FOR THE PREPARATION OF A DERMOCOSMETIC COMPOSITION, DERMOCOSMETIC COMPOSITION CONTAINING THIS MIXTURE, AND METHOD FOR THE PREPARATION OF THIS MIXTURE |
FR2746008B1 (en) * | 1996-03-14 | 1998-05-29 | COMPOSITION FOR TOPICAL USE ANTI-AGING | |
US6162419A (en) * | 1996-11-26 | 2000-12-19 | Nicholas V. Perricone | Stabilized ascorbyl compositions |
JP2002507202A (en) * | 1997-06-20 | 2002-03-05 | マリー カイ インコーポレーテッド | Cosmetic composition containing whitening agent and descaling agent |
DE19750030A1 (en) | 1997-11-12 | 1999-05-20 | Merck Patent Gmbh | Light-stable cosmetic formulation containing butyl methoxydibenzoyl methane |
DE19755504A1 (en) * | 1997-12-13 | 1999-06-17 | Beiersdorf Ag | Use of flavone derivatives in cosmetic or dermatological compositions |
DE19807774A1 (en) * | 1998-02-24 | 1999-08-26 | Beiersdorf Ag | Use of flavone, flavanone or flavonoid compound for protection of ascorbic acid or ascorbyl compound against oxidation, especially in cosmetic and dermatological preparations, |
EP1073446B1 (en) * | 1998-04-29 | 2009-01-07 | Avon Products, Inc. | Skin whitening composition |
DE19845322A1 (en) * | 1998-10-01 | 2000-04-06 | Beiersdorf Ag | Active combination based on flavone, flavanone and/or flavonoid, useful in cosmetic and dermatological formulations, contains 2-tert.-butyl hydroquinone |
DE19845266A1 (en) * | 1998-10-01 | 2000-04-06 | Beiersdorf Ag | Use of butylhydroxytoluene for stabilizing flavone, flavanone and/or flavonoid useful in cosmetic and dermatological formulations |
DE19845319A1 (en) * | 1998-10-01 | 2000-04-06 | Beiersdorf Ag | Use of mono-, oligo- and polymeric ethers, esters and ether-ester surfactants for stabilizing flavone, flavanone and/or flavonoid useful in cosmetic and dermatological formulations |
EP1128805A1 (en) * | 1998-11-13 | 2001-09-05 | The Procter & Gamble Company | An oil-in-water emulsion containing an ascorbic acid compound |
CZ20011582A3 (en) * | 1998-11-13 | 2001-08-15 | The Procter & Gamble Company | Skin lightening composition |
US5980904A (en) * | 1998-11-18 | 1999-11-09 | Amway Corporation | Skin whitening composition containing bearberry extract and a reducing agent |
FR2787710B1 (en) * | 1998-12-29 | 2001-02-23 | Clarins | COSMETIC COMPOSITION WITH LIGHTENING EFFECT FOR THE SKIN |
DE19923715A1 (en) * | 1999-05-22 | 2000-11-23 | Beiersdorf Ag | Cosmetic or dermatological sunscreen preparations containing flavone derivatives and / or flavanone derivatives, in particular flavonoids and s-triazine, and the use of UV filter substances having the structural motif of s-triazine for stabilizing flavone derivatives and / or flavanone derivatives, in particular flavonoids |
DE19923713A1 (en) * | 1999-05-22 | 2000-11-23 | Beiersdorf Ag | Cosmetic or dermatological sunscreen preparations containing flavone derivatives and / or flavanone derivatives, in particular flavonoids and benzotriazole, and the use of UV filter substances having the structural motif of benzotriazole for stabilizing flavone derivatives and / or flavanone derivatives, in particular flavonoids |
DE19923712A1 (en) * | 1999-05-22 | 2000-11-23 | Beiersdorf Ag | Active substance combination of sulfonated UV filter substances and flavone derivatives and / or flavanone derivatives, in particular flavonoids, and cosmetic preparations containing such active substance combinations |
DE19925499A1 (en) * | 1999-06-04 | 2000-12-07 | Beiersdorf Ag | Use of ascorbic acid and one or more flavone derivatives and / or flavonone derivatives, in particular flavonoids, for the preparation of cosmetic or dermatological preparations for the prophylaxis or relief of sunburn |
EP1210077A4 (en) * | 1999-06-15 | 2002-12-18 | Benjamin D Gordon | Compositions and systems for the treatment of hyperpigmentation |
GB9917729D0 (en) | 1999-07-28 | 1999-09-29 | Boots Co Plc | Hair care composition |
US6521668B2 (en) * | 1999-12-14 | 2003-02-18 | Avon Products, Inc. | Cosmetic composition and methods of use |
US20020016358A1 (en) * | 2000-04-19 | 2002-02-07 | Nof Corporation | Cosmetic composition |
GB0026018D0 (en) * | 2000-10-24 | 2000-12-13 | Novartis Nutrition Ag | New composition |
FR2816502B1 (en) * | 2000-11-10 | 2003-04-11 | Oreal | COSMETIC COMPOSITION CONSISTING OF AN AMINOPHENOL DERIVATIVE AND AN ISOFLAVONOIDE |
JP2002212054A (en) * | 2001-01-16 | 2002-07-31 | Tsumura & Co | Bathing agent composition |
US7189759B2 (en) | 2001-05-23 | 2007-03-13 | Medicis Pharmaceutical Corporation | Compositions for the treatment of pigmentation disorders and methods for their manufacture |
JP2005507946A (en) * | 2001-11-09 | 2005-03-24 | バイヤースドルフ・アクチエンゲゼルシヤフト | Cosmetic and / or dermatological preparations containing octadecenedicarboxylic acid and UV filter substance |
DE10215342A1 (en) * | 2002-03-28 | 2003-10-23 | Coty Bv | Skin lightening cosmetic |
US6844014B1 (en) | 2002-07-22 | 2005-01-18 | Stephen Rafkin | Herbal healing lotion for veterinary use |
DE10238449A1 (en) * | 2002-08-22 | 2004-03-04 | Beiersdorf Ag | Cosmetic and / or dermatological preparation |
KR101161568B1 (en) | 2003-12-15 | 2012-07-04 | 포라 가세이 고교 가부시키가이샤 | External preparations for skin |
US7429391B2 (en) * | 2004-01-30 | 2008-09-30 | Access Business Group International Llc | Holistic composition and method for reducing skin pigmentation |
CN1960700A (en) * | 2004-03-30 | 2007-05-09 | 荷兰联合利华有限公司 | Skin lightening compositions comprising vitamines and flavonoids |
DE102004042299A1 (en) | 2004-08-27 | 2006-03-23 | Lancaster Group Gmbh | Cosmetic brightening and cleansing agent for skin, comprises complex of plant extract, and conventional cosmetic carriers, additives and other active substances |
ES2255862B1 (en) * | 2004-12-27 | 2007-07-16 | Sesderma, S.L. | ADDITIVES FOR CUTANEOUS PEELINGS. |
DE102007007612A1 (en) * | 2007-02-13 | 2008-08-14 | Beiersdorf Ag | Method for depigmenting the skin |
EP2444061B1 (en) * | 2009-06-17 | 2018-11-28 | Kao Corporation | Apigenin-containing composition |
KR101716325B1 (en) * | 2011-02-28 | 2017-03-15 | (주)아모레퍼시픽 | Method for generating thermal protection index |
TW201532621A (en) * | 2013-04-22 | 2015-09-01 | Neocutis Sa | Antioxidant compositions and methods of using the same |
DE102013208865A1 (en) * | 2013-05-14 | 2014-11-20 | Beiersdorf Ag | Stabilized preparations containing ascorbic acid and phosphate ions |
US9132117B2 (en) | 2013-06-17 | 2015-09-15 | Kgk Synergize, Inc | Compositions and methods for glycemic control of subjects with impaired fasting glucose |
CN105125418A (en) * | 2014-05-31 | 2015-12-09 | 尹连花 | Skin care and speckle reduction cream preparation and preparation method thereof |
DE102014211185A1 (en) | 2014-06-11 | 2015-12-17 | Henkel Ag & Co. Kgaa | Cosmetic compositions for skin lightening |
GB2544046A (en) * | 2015-10-30 | 2017-05-10 | Boots Co Plc | Skin care composition and method thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2543437B1 (en) * | 1983-03-30 | 1987-07-10 | Duraffourd Alain | COMPOSITION FOR REGENERATING COLLAGEN OF CONNECTIVE TISSUE OF THE SKIN AND METHOD FOR PREPARING SAME |
FR2582941B3 (en) * | 1985-06-11 | 1987-10-09 | Moreau Lavaud Reine | COSMETIC COMPOSITION BASED ON EXTRACTS OF MURIER LEAVES |
JPS6360911A (en) * | 1986-09-01 | 1988-03-17 | Riyuuhoudou Seiyaku Kk | Ascorbic acid-containing composition |
FR2616328B1 (en) * | 1987-06-12 | 1990-03-02 | Moet Hennessy Rech | COMPOSITION BASED ON HYDRATED LIPID LAMID PHASES OR LIPOSOMES CONTAINING MURIER EXTRACT, OR AT LEAST ONE FLAVONE, PARTICULARLY A KUWANONE AND PHARMACEUTICAL COMPOSITION, ESPECIALLY DERMATOLOGICAL, WITH DEPIGMENTARY, OR ANTI-INFLAMMENT ACTIVITY, OR ANTI-INFLAMENT, |
JPH0278611A (en) * | 1988-09-13 | 1990-03-19 | Kansai Paint Co Ltd | Skin cleaning agent |
GB8910366D0 (en) * | 1989-05-05 | 1989-06-21 | Unilever Plc | Skin composition |
TW197375B (en) * | 1990-11-19 | 1993-01-01 | Hayashibara Biochem Lab |
-
1991
- 1991-08-23 IL IL99291A patent/IL99291A/en not_active IP Right Cessation
-
1992
- 1992-08-20 CA CA002076467A patent/CA2076467A1/en not_active Abandoned
- 1992-08-21 DE DE4227806A patent/DE4227806A1/en not_active Withdrawn
- 1992-08-21 GB GB9217821A patent/GB2259014B/en not_active Expired - Fee Related
- 1992-08-21 CH CH2610/92A patent/CH684739A5/en not_active IP Right Cessation
- 1992-08-21 ES ES09201822A patent/ES2050074B1/en not_active Expired - Lifetime
- 1992-08-21 AU AU21220/92A patent/AU654030B2/en not_active Ceased
- 1992-08-21 FR FR9210195A patent/FR2680466B3/en not_active Expired - Lifetime
- 1992-08-21 PT PT100800A patent/PT100800B/en not_active IP Right Cessation
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2712806A1 (en) * | 1991-12-19 | 1995-06-02 | Dowa Mining Co | Skin-cosmetic material having high whitening effect and safety |
FR2708851A1 (en) * | 1993-08-12 | 1995-02-17 | Oreal | Cosmetic composition comprising the combination of a nanopigment of metal oxides and an antioxidant, and use thereof for protecting the skin and the hair |
FR2717386A1 (en) * | 1994-03-17 | 1995-09-22 | Fischer Pharma Ltd | Composition for whitening the skin. |
FR2723316A1 (en) * | 1994-08-04 | 1996-02-09 | Thorel Jean Noel | Compsn. for skin de-pigmentation caused by hyper:activation melanocytes |
US5882658A (en) * | 1995-07-20 | 1999-03-16 | L'oreal | Composition for combatting skin blemishes and/or ageing of the skin, and uses thereof |
FR2736829A1 (en) * | 1995-07-20 | 1997-01-24 | Oreal | COMPOSITION FOR PREVENTING SKIN TASKS AND / OR SKIN AGING, USES THEREOF |
EP0754449A1 (en) * | 1995-07-20 | 1997-01-22 | L'oreal | Skin whitening composition and/or anti-aging composition and uses thereof |
EP1075833A1 (en) * | 1999-07-22 | 2001-02-14 | The Secretary Of State For Defence | Barrier cream |
US6309631B1 (en) | 1999-07-22 | 2001-10-30 | Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland | Barrier cream |
US7182949B2 (en) * | 2001-02-19 | 2007-02-27 | L'oreal | Composition comprising vitamin C prepared during application, use of enzymes for forming vitamin C for topical use, and a cosmetic treatment method |
WO2002067886A3 (en) * | 2001-02-28 | 2003-03-20 | Colgate Palmolive Co | Skin composition |
EP1709964A2 (en) * | 2005-04-06 | 2006-10-11 | Engelhard Lyon | A method of cosmetic depigmentation care by applying at least one aurone |
FR2884250A1 (en) * | 2005-04-06 | 2006-10-13 | Coletica Sa | USE OF AURONES FOR THE DEPIGMENTING OR INHIBITING ACTIVITY OF MELANOGENESIS IN COSMETIC OR DERMATOLOGICAL COMPOSITIONS |
EP1709964A3 (en) * | 2005-04-06 | 2006-10-18 | Engelhard Lyon | A method of cosmetic depigmentation care by applying at least one aurone |
FR3007981A1 (en) * | 2013-07-05 | 2015-01-09 | Oreal | ASSOCIATION OF EXTRACT OF HAMAMELIS VIRGINIANA, ESCIN, AND ASCORBIC ACID |
Also Published As
Publication number | Publication date |
---|---|
FR2680466B3 (en) | 1993-11-19 |
GB9217821D0 (en) | 1992-10-07 |
PT100800B (en) | 1999-07-30 |
CA2076467A1 (en) | 1993-02-24 |
AU654030B2 (en) | 1994-10-20 |
PT100800A (en) | 1994-02-28 |
IL99291A (en) | 1997-04-15 |
IL99291A0 (en) | 1992-07-15 |
ES2050074A1 (en) | 1994-05-01 |
CH684739A5 (en) | 1994-12-15 |
ES2050074B1 (en) | 1994-12-16 |
GB2259014A (en) | 1993-03-03 |
AU2122092A (en) | 1993-02-25 |
DE4227806A1 (en) | 1993-02-25 |
GB2259014B (en) | 1996-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2680466A1 (en) | PREPARATION FOR WHITENING THE SKIN. | |
KR100402976B1 (en) | Skin whitening composition containing bearberry extract and a reducing agent | |
DE202015009464U1 (en) | cosmetic compositions | |
US20100104524A1 (en) | Cosmetic composition for skin whitening comprising arctiin, arctigenin or the mixture thereof as active | |
US6436378B1 (en) | Composition | |
US20200306172A1 (en) | Depigmenting dermatological and cosmetic compositions | |
JPH0527605B2 (en) | ||
CN115087427A (en) | Herbal cosmetic composition for treating skin | |
US8481006B2 (en) | Melt formula | |
KR20060135722A (en) | Topical depigmenting formulations comprising an extract of bellis perennis | |
KR20130099058A (en) | Compositions comprising paulownin and/or paulownia extracts and uses thereof | |
KR101921043B1 (en) | Compositions comprising lilium martagon extracts and uses thereof | |
KR101921044B1 (en) | Compositions comprising lilium martagon extracts and uses thereof | |
FR2723316A1 (en) | Compsn. for skin de-pigmentation caused by hyper:activation melanocytes | |
KR20150044817A (en) | Compositions comprising paulownia tomentosa wood extracts and uses thereof | |
KR20140133458A (en) | Compositions comprising extracts of bursera simaruba | |
US20120045530A1 (en) | Compositions comprising paulownia tomentosa wood extracts and uses thereof | |
FR2885128A1 (en) | DEPIGMENTING OR LIGHTENING COSMETIC COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE AS AN ACTIVE INGREDIENT DEPIGMENTING OR LIGHTENING | |
JPH05294819A (en) | Beautifying cosmetic | |
JPH09157151A (en) | Melanin generation inhibitor and whitening agent | |
KR100430606B1 (en) | Cosmetic Compositions Comprising Lactic Acid and Arbutin for Skin Whitening | |
KR100540854B1 (en) | Cosmetic Compositions for Skin-Whitening Comprising Phytolight and Lactate as Active Ingredients | |
CN115177565B (en) | Whitening and skin brightening composition and application thereof in cosmetics | |
JPH1036215A (en) | External preparation for skin | |
JPH11139932A (en) | Preparation for external use for skin whitening |